Search Results 391-400 of 17334 for Spermatogenesis

  1. Obstetrics and Gynecology - Doctors - Mayo Clinic

    Mayo Clinic's Department of Obstetrics and Gynecology offers prevention, diagnosis and treatment for women from childbearing age to menopause and beyond.

  2. Obstetrics and Gynecology - Doctors - Mayo Clinic

    Mayo Clinic's Department of Obstetrics and Gynecology offers prevention, diagnosis and treatment for women from childbearing age to menopause and beyond.

  3. Vaginal agenesis - Doctors and departments - Mayo Clinic

    In this rare condition that occurs before birth, the vagina doesn't develop and the uterus may only develop partially or not at all. Learn about treatment.

  4. A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients with Gastrointestinal Stromal Tumour After Progression with Imatinib - Mayo Clinic

    A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Sunitinib in Patients with Gastrointestinal Stromal Tumour After Progression with ...

  5. Publications - Bernard J. Kuipers, M.D. - Mayo Clinic

    Butterfield JH, Schwenk NF, Colville D, Kuipers BJ. Severe generalized reactions to ibuprofen. J Rheumatol. 1986; 13:649-650. View PubMed. PST-20222435.

  6. Publications - P. Pearse P. Morris, M.B., B.Ch. - Mayo Clinic

    Madhavan AA, Lutzen N, Cutsforth-Gregory JK, Schievink WI, Kodet ML, Mark IT, Morris PP, Messina SA, Wald JT, Brinjikji W. Additional Diagnostic Value of ...

  7. A Study to Assess Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally-advanced Breast Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study of the Safety and Effectiveness of HBI-8000 with Nivolumab to Treat Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung Cancer - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. LS1681: A Study of AR160 in Treating Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, work in different ways to stop the growth of tumor cells, either by ...